pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. In addition, she worked as head of inspectorate and licensing for the MHRA from 2004-2006. She joined NSF in 2017.

Pharma 112

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 112

European Pharmaceutical Review

AUGUST 22, 2022

1 This has led to a great deal of pre-competitive data sharing. As the data is anonymised it will not be possible to select excipient suppliers based on lowest available nitrite levels, but it may prompt some suppliers to publish this information as it could provide a competitive advantage. 2022 [cited 30 July 2022]. Assessment report.

Food and Drug Administration 59

Food and Drug Administration Prescription Food Medicine 59

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, Tysabri was performing well, having yielded $776 million in sales after being first approved in 2004, as per Biogen’s 2009 financial filings. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Government 59

Government Specialization Physicians Education 59

European Pharmaceutical Review

AUGUST 23, 2022

Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. In addition, he was Head of the Legal Service at the European Medicines Agency from 2004 to 2012.

Consulting 96

Consulting Medical Healthcare Healthcare 96

CloserIQ

OCTOBER 10, 2018

Founded 2004. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Founded 2004. The company is known for its welcoming, laidback culture. They are hiring BDRs and other sales professionals.

Sales 76

Sales Management Education Marketing 76

PM360

SEPTEMBER 28, 2022

PM360 spoke to Kokino about the evolution of the biosimilars market from its nascent days, why the now increased competition within the market is causing some companies to reconsider developing biosimilars, what to look for over the next few years, and how Accord’s approach is a bit different from what other companies are doing.

Competition 98

Competition Marketing Biopharma Manufacturing 98

PM360

JUNE 29, 2022

However, patient uptake hasn’t matched rising market competition. Among surveyed patients, nearly half (47%) couldn’t remember a single preventive migraine brand name, and the leading brand patients did recall— Topamax —is an older drug that was approved for migraine in 2004.

Prescription 98

Prescription Patients Pharma Doctors 98

Pharmaceutical Technology

JULY 10, 2008

This is confirmed by the Centre for Medicines Research International which shows in 2004 that more than 20% of the money invested in R&D by ten of the largest pharmaceutical companies went on line extensions, as opposed to new development projects. %, while R&D accounts for just 17.1%

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Government 95

Government Medical Medicine Marketing 95

Evolve Your Success

NOVEMBER 14, 2023

I did an internship and live with them for the summer in 2004 when I started a company. My cousin and his wife started a women’s jewelry company several years ago based out in Laguna Beach, California. I watched them start the company when I was a senior in college. I saw the blood, sweat, tears, and the passion that went behind that.

Medical sales 52

Medical sales Medicine Medical Sales 52

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

APRIL 12, 2023

This is to ensure patient safety, as outlined in The Medicines for Human Use (Clinical Trials) Regulations 2004. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98

Cadensee

JULY 20, 2021

When he was going through his cancer, he died in 2004. But in terms of Israel as a competitive advantage, I think data is much more than just good technology. Uri Goren: So, I guess my fascination with this came through a personal experience. So, I myself, was a care giver for my father.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52